January 18, 2022 Sophia Vida

Nutra Pharma Letter to Shareholders

  Nutra Pharma has published their annual letter to shareholders to the Company’s website   Plantation, Florida, Jan. 18, 2022 — McapMediaWire — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away, Luxury Feet and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) … Continue reading “Nutra Pharma Letter to Shareholders”